CN Stock MarketDetailed Quotes

Zhejiang Jiuzhou Pharmaceutical (603456)

Watchlist
  • 19.64
  • -0.10-0.51%
Trading Jan 16 14:51 CST
17.47BMarket Cap24.16P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Zhejiang Jiuzhou Pharmaceutical (603456) Revenue Breakdown Overview

By Product

Currency:CNY
2025/H1
Stock NameRevenueRatio
新药定制研发和生产服务(CDMO)2.29B79.81%
Specialty APIs and intermediates523.21M18.22%
Other56.36M1.96%

By Industry

Currency:CNY
2024/FY
Stock NameRevenueRatio
Production, marketing and service of chemical raw materials and intermediates5.09B98.56%
Other business74.24M1.44%

By Country/Region

Currency:CNY
2025/H1
Stock NameRevenueRatio
Export sales2.29B79.90%
Domestic sales577.18M20.10%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
HK Tech and Internet Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +17.33%
Sample Name
Sample Code
 +16.47%
Sample Name
Sample Code
 +13.04%
4
BIDU-SW
09888
+5.68%
5
JD HEALTH
06618
+4.78%
View More
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +6.63%
Sample Name
Sample Code
 +3.27%
Sample Name
Sample Code
 +2.15%
4
NVIDIA
NVDA
+2.13%
5
Broadcom
AVGO
+0.92%
Will the 'tariff stick' strike again? Will the market remain 'reactive'?
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"

- No more -